Bone-independent extramedullary disease is associated with inferior overall survival in multiple myeloma patients: a single center, real-world experience
Not available.
Saved in:
| Main Authors: | Ke Xu, Charles Agbuduwe, Nickolaos Kanellias, William Wilson, Annabel McMillan, Xenofon Papanikolaou, Lydia Lee, Rakesh Popat, Jonathan Sive, Neil Rabin, Kwee Yong, Agapi Parcharidou, Charalampia Kyriakou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2024-12-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/11864 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outcomes of melphalan 140 mg/m2 followed by autologous stem cell transplantation in multiple myeloma patients with co‐morbidities: Single‐centre experience
by: Dario Melotti, et al.
Published: (2024-10-01) -
Extramedullary CNS myeloma
by: Alessandro Gozzetti
Published: (2025-06-01) -
Extramedullary Multiple Myeloma: Challenges and Opportunities
by: Matthew Ho, et al.
Published: (2025-03-01) -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
by: Bart Barlogie, et al.
Published: (2011-01-01) -
Multiple myeloma with extramedullary plasmacytoma: pathogenesis and clinical case
by: M. V. Firsova, et al.
Published: (2022-11-01)